Therapeutic potential and novel formulations of ursolic acid and its derivatives: an updated review
- PMID: 36597140
- DOI: 10.1002/jsfa.12423
Therapeutic potential and novel formulations of ursolic acid and its derivatives: an updated review
Abstract
Plants produce biologically active metabolites that have been utilised to cure a variety of severe and persistent illnesses. There is a possibility that understanding how these bioactive molecules work would allow researchers to come up with better treatments for diseases including malignancy, cardiac disease and neurological disorders. A triterpene called ursolic acid (UA) is a pentacyclic prevalent triterpenoid found in fruits, leaves, herbs and blooms. The biological and chemical aspects of UA, as well as their presence, plant sources and biosynthesis, and traditional and newer technologies of extraction, are discussed in this review. Because of its biological function in the creation of new therapeutic techniques, UA is a feasible option for the evolution and medical management of a wide range of medical conditions, including cancer and other life threatening diseases. Despite this, the substance's poor solubility in aquatic environments makes it unsuitable for medicinal purposes. This hurdle was resolved in many different ways. The inclusion of UA into various pharmaceutical delivery approaches was found to be quite effective in this respect. This review also describes the properties of UA and its pharmacokinetics, as well as therapeutic applications of UA for cancer, inflammatory and cardiovascular diseases, in addition to its anti-diabetic, immunomodulatory, hepatoprotective and anti-microbial properties. Some of the recent findings related to novel nano-sized carriers as a delivery system for UA and the patents related to the applications of UA and its various derivatives are covered in this review. The analytical study of UA, oleanolic acid and other phytoconstituents by UV, HPLC, high-performance thin-layer chromatography and gas chromatography is also discussed. In the future, UA could be explored in vivo using various animal models and, in addition, the regulatory status regarding UA needs to be explored. © 2023 Society of Chemical Industry.
Keywords: biological effects; derivatives; drug delivery system; triterpenoids; ursolic acid.
© 2023 Society of Chemical Industry.
References
REFERENCES
-
- Kaps A, Gwiazdon P and Chodurek E, Nanoformulations for delivery of pentacyclic triterpenoids in anticancer therapies. Molecules 26:1764 (2021). https://doi.org/10.3390/molecules26061764.
-
- De Oliveira JR, Camargo SEA and de Oliveira LD, Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent. J Biomed Sci 26:5 (2019). https://doi.org/10.1186/s12929-019-0499-8.
-
- Swiezewska E and Danikiewicz W, Polyisoprenoids: structure, biosynthesis and function. Prog Lipid Res 44:235-258 (2005). https://doi.org/10.1016/j.plipres.2005.05.002.
-
- Thimmappa R, Geisler K, Louveau TO, Maille P and Osbourn A, Triterpene biosynthesis in plants. Annu Rev Plant Biol 65:225-257 (2014). https://doi.org/10.1146/annurev-arplant-050312-120229.
-
- Fernandez-Hernandez A, Martinez A, Rivas F, García-Mesa JA and Parra A, Effect of the solvent and the sample preparation on the determination of triterpene compounds in two-phase olive-mill-waste samples. J Agric Food Chem 63:4269-4275 (2015). https://doi.org/10.1021/jf506171y.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
